About us

Meddroid Pharma Director

Meddroid Pharma has its roots in United Kingdom and has been introduced to the world by its director Dr. Med O’Smith and a small group of highly committed professionals in the year 2010 as a private enterprise to be in the field of research, developing, engineering and promoting of pharmaceutical drugs and complete dosage forms for UK & US markets. The company began its full flown operations in 2010 in Greater London, United Kingdom.

Meddroid Pharma, a leading pharmaceutical company that has been operating in the UK and USA for several years by director of Meddroid pharma Dr. Smith, specializes in developing and manufacturing innovative drugs and therapies that help improve the health and well being of people around the world.

The company was classified one of the leading among pharmaceutical companies in 2019 in its category. Meddroid also has the credit of being one of the largest contract manufacturers in UK and India as wel

Meddroid Pharma is Great Place To Work

Meddroid have been able to create several breakthrough products that have been approved by regulatory bodies in both UK and USA. The commitment to quality and excellence has earned Meddroid a reputation as a trusted and reliable partner in the healthcare industry.

Meddroid Pharma having its roots in UK has now expanded its operations to other parts of the world viz., Gulf, South-Asia and particularly India, one of the world’s fastest-growing pharmaceutical market and have established a state-of-the-art manufacturing facility in India that is equipped with the latest technology 

The goal of Meddroid Pharma is to leverage expertise and resources to develop and deliver high-quality drugs and therapies that address the most pressing healthcare needs of the country, with a belief that their presence will help to reach a wider audience and make a significant contribution to the health and well-being of the people of the world.

Business Area of the Company

Meddroid manufactures/manufacturers a comprehensive range of branded and generic dosage forms, bulk actives and intermediates for both UK as well as US markets.The portfolio includes a range of products in different therapeutic areas, including

 Includes drugs for the treatment of hypertension, heart failure, and angina. The products in this category are designed to improve blood flow and reduce the risk of heart-related complications.

 Include a wide range of inhalers and nebulizers for the treatment of respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD).

 Includes drugs for the treatment of neurological disorders, such as epilepsy, Parkinson's disease, and Alzheimer's disease. These drugs are designed to improve cognitive function and reduce the risk of seizures.

 Includes a range of drugs for the treatment of various types of cancer, such as breast cancer, lung cancer, and prostate cancer. Our drugs are designed to target cancer cells and reduce the risk of cancer progression.

 Includes drugs for the treatment of autoimmune diseases, such as rheumatoid arthritis and psoriasis. These drugs are designed to reduce inflammation and improve quality of life for patients

 Includes wide range of drugs in treating, and managing conditions affecting the organs, including urinary tract infections, kidney stones, prostate cancer, bladder problems and infertility. They also show effective results in lifestyle changes that can help improve overall health. With the quality and efficacy in this field, we have become essential healthcare providers.

 A rapidly evolving field of healthcare that focuses on providing life- saving treatments to patients with severe and life-threatening illnesses or injuries. Through the use of advanced medical technology, critical care medicine has been able to save many lives and improve the quality of life for those who are critically ill. In this field Meddroid continues to expand and develop, will become even more important in providing the best possible care for those who need it most.

Meddroid Pharma Director Message

I am delighted to connect with each of you and share the exciting trajectory that lies ahead for Meddroid Pharma, our esteemed organization. As the Director of Meddroid Pharma, it brings me great joy to articulate our vision, values, and the collective aspirations we hold for our shared success.

 At the heart of our mission is an unwavering commitment to enriching lives through innovative healthcare solutions. We firmly believe in ensuring that every individual has access to safe, effective, and affordable medications, contributing to their overall well-being. Guided by this principle, we’ve assembled a team of dedicated professionals who share a passionate commitment to making a positive impact on global health.

Certification / Recognition

ISO 9002 certified dosage facility ISO–14001 certificate

Operational Excellence

Vertical integration
Proven regulatory expertise
Technology and know-how for speciality formulations

Strengths and Leadership

Large-manufacturing facilities approved by leading regulatory bodies
Large diversified product portfolio
Large R&D facility in UK for formulations and active ingredients